These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transplastomic expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: a step towards cost-effective second-generation vaccines. Waheed MT, Thönes N, Müller M, Hassan SW, Razavi NM, Lössl E, Kaul HP, Lössl AG. Transgenic Res; 2011 Apr; 20(2):271-82. PubMed ID: 20563641 [Abstract] [Full Text] [Related]
11. Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic. Chen Y, Liu Y, Zhang G, Wang A, Dong Z, Qi Y, Wang J, Zhao B, Li N, Jiang M. Virus Res; 2016 Jul 15; 220():97-103. PubMed ID: 27107614 [Abstract] [Full Text] [Related]
14. [Prokaryotic expression of HPV 16 L1 gene and identification of its immune activity]. Hao DF, Ma ZH, Wang YP, Rexidan, Zhang FC. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul 15; 21(4):428-31. PubMed ID: 15989783 [Abstract] [Full Text] [Related]
16. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. Sehr P, Müller M, Höpfl R, Widschwendter A, Pawlita M. J Virol Methods; 2002 Oct 15; 106(1):61-70. PubMed ID: 12367730 [Abstract] [Full Text] [Related]
17. Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection. Jagu S, Kwak K, Garcea RL, Roden RB. Vaccine; 2010 Jun 17; 28(28):4478-86. PubMed ID: 20434552 [Abstract] [Full Text] [Related]